Drug profile · INN
alectinib hydrochloride
ALECENSA
alectinib hydrochloride (ALECENSA) is a eml4-alk. Route of administration: oral. Current US regulatory status: approved.
Drug details — alectinib hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
alectinib hydrochloride (ALECENSA) is a eml4-alk. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
EML4-ALK
Primary target: ALK tyrosine kinase receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| PMDA | approved | — |
Recent coverage
Roche's Alecensa Secures Expanded Approval in Japan for ALK-Positive Lung Cancer
Roche has secured an expanded approval for Alecensa in Japan, broadening its therapeutic reach for patients with ALK-positive non-small cell lung cancer. This development underscores Roche's commitment to advancing targeted therapies in oncology.
Roche Expands Alecensa Approval in Japan: Implications for Pharma
Roche has received approval to expand Alecensa's use in Japan for all ALK tumor types. This article explores the implications for pharma stakeholders.
Roche's Alecensa Expansion: Implications for Pharma Stakeholders
Roche's Alecensa has received approval for the treatment of all ALK tumor types in Japan, marking a significant regulatory milestone. This article explores the implications for pharma stakeholders.
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is alectinib hydrochloride?
alectinib hydrochloride (ALECENSA) is a eml4-alk. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for alectinib hydrochloride?
ALECENSA is a marketed brand name for alectinib hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alectinib hydrochloride?
alectinib hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.